GSK2110183盐酸盐
Afuresertib-F HCl | GSK2110183-analog 1 HCl |
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Afuresertib-F HCl | GSK2110183-analog 1 HCl |
CAS2070009-64-0
FormulaC18H17Cl3F2N4OS
MW481.77
Storage condition-20°C, protect from light, stored under nitrogen
Security information
Product details

GSK2110183 HCl, an analog ofAfuresertib, is a potent, orally bioavailable andATP-competitive Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively.

Related literature
Related
Afuresertib-F free base | Afuresertib-F free base | GSK-2110183-analog 1
Afuresertib HCl | Afuresertib hydrochloride | GSK2110183 hydrochloride | LAE002 hydrochloride
Afuresertib | GSK2110183 | LAE002
History
Ridaforolimus (Synonyms: MK-8669; Deforolimus; AP23573; 42-(二甲基亚膦酰)雷帕霉素)
Valrubicin | AD-32
Miriplatin hydrate (Synonyms: SM-11355 hydrate)
Pamidronic Acid
Vorolanib (X-82,CM082)
Valbenazine Tosylate (Synonyms: Valbenazine Ditosylate; NBI-98854 Tosylate)
Afuresertib-F HCl | GSK2110183-analog 1 HCl |
Pinobanksin 3-acetate ((2R,3R)-Pinobanksin 3-acetate; Pinobanksin 3-O-acetate; Pinobanksin acetate)
5-ALA (Synonyms: 5-Aminolevulinic Acid Phosphate; 5-Amino-4-oxopentanoic acid phosphate)
(R)-(-)-YM12617 free base | LY253351 free base